• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Buyouts

Intriva buys Sequence Care from Horizon

  • Harriet Matthews
  • Harriet Matthews
  • 29 September 2021
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Intriva Capital has acquired UK-based adult social care provider Sequence Care Group from Horizon Capital.

Intriva was formed in 2017 and is headed by managing partner Simon Finn (formerly of Apollo Global Management). The GP generally invests in special situations in the western European market, aiming to create sustainable value via strategic, operational and financial improvements.

According to press reports, the GP is now on the road for its second fund, which has a EUR 300m target.

Sequence Care Group

  • DEAL:

    SBO

  • LOCATION:

    London

  • SECTOR:

    Healthcare providers

  • FOUNDED:

    2001

  • EBITDA:

    GBP 9m (est)

  • STAFF:

    760

  • VENDOR:

    Horizon Capital

Following Intriva's investment, Sequence intends to develop new homes to care for residents with learning disabilities and physical disabilities. The company also plans to make add-ons in the UK.

Virgin Money has provided senior debt to back the deal.

Unquote sister publication Mergermarket reported in November 2020 that Sequence was up for sale, with Grant Thornton advising on the process. Sources told Mergermarket that the company posted around GBP 7m in EBITDA.

Horizon Capital is a spin-off from Lyceum Capital, which announced in 2018 that it planned to raise capital on a deal-by-deal basis and to halt fundraising for its fourth vehicle, as reported. Horizon continued to manage Lyceum's existing portfolio companies, participating in a tender offer to buy stakes from LPs who wanted to exit their investment.

The GP acquired a minority stake in Sequence Care (then known as CuroCare) in a GBP 25m deal in 2013. Lyceum invested via its third fund, which held a final close in May 2013 on its GBP 330m hard-cap. The fund invested tickets of GBP 5m-50m in UK-based companies operating in fragmented markets.

Horizon Capital raised its first fund following the spin-off in 2018. Horizon Capital I held a final close in October 2018 on GBP 200m. The fund makes investments of GBP 10m-50m and saw the team shift its focus to backing UK-based technology and services businesses.

Sequence Care is no longer listed as a current or realised portfolio company of Horizon Capital on its website; however, the GP is still a party with significant control in the company, according to Sequence Care's public filings.

Horizon Capital had not responded to a request for comment at the time of publication.

Unquote reported earlier this month on the upcoming UK social care reforms and their potential impact for private equity activity in the sector, concluding that PE players remain optimistic about the prospects for investment in the sector, with opportunities expected to arise from demographic change, and the integration of technology and data into care models.

Company
Founded in 2001, Sequence Care provides specialist care for adults with learning disabilities, challenging behaviours or physical disability, and autism through residential care and supported living. The business has three brands: Sequence Care, Progress Housing and Liaise Loddon. Sequence Care generates EBITDA of around GBP 9m.

The company employs more than 760 staff across its 37 care and supported living homes in London and the south of England.

People
Intriva Capital – Simon Finn (managing partner).
Sequence Care Group – Tony Hegarty (CEO).

Advisers
Equity – Connell Consulting (commercial due diligence); Taylor Wessing (legal); McDermott Will & Emery (debt advisory); Axis Arbor (debt advisory).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Buyouts
  • Exits
  • Healthcare
  • United Kingdom
  • Secondary buyout
  • Horizon Capital (formerly Lyceum Capital)

More on Buyouts

Container transport and logistics
CVC acquires Scan Global logistics from AEA Investors

AEA and management have reinvested for a minority stake in the Danish logistics provider

  • Buyouts
  • 06 February 2023
Indian restaurants and cuisine
Foresight reaps 3.5x money in Mowgli exit to TriSpan

Sale of Indian restaurant chain is the sixth exit from the firm’s first Regional Investment fund

  • Exits
  • 30 January 2023
Online data services
SoftwareONE on PE watchlist amid take-private optimism

Switzerland-listed cloud technology group has been eyed by several buyout houses in recent months

  • Buyouts
  • 30 January 2023
Stock market trackers and financial investment apps
Equistone to exit Acuity in sale to Permira

Sale of financial services research group follows process with early discussions between vendor and bidders

  • Exits
  • 27 January 2023

Latest News

Container transport and logistics
  • Buyouts
CVC acquires Scan Global logistics from AEA Investors

AEA and management have reinvested for a minority stake in the Danish logistics provider

  • 06 February 2023
Jean-Charles Decaux of Eurazeo
  • People
Eurazeo shakes up executive board; CEO Virginie Morgon to depart

New board members are chairmen Christophe Bavière and William Kadouch-Chassaing, as well as Sophie Flak and Olivier Millet

  • 06 February 2023
Human microbiome
  • Venture
Seventure preps third generation of microbiome fund

Health for Life III to be slightly larger than EUR 250m predecessor; will invest in Europe, US, Israel

  • 06 February 2023
Cem Baytok of Idacapital
  • Venture
Idacapital targets close to USD 30m for impact fund

Turkish VC seeks to raise USD 5m every six months for new rolling investment vehicle

  • 06 February 2023
Back to Top

Most read

Container transport and logistics
CVC acquires Scan Global logistics from AEA Investors
Jean-Charles Decaux of Eurazeo
Eurazeo shakes up executive board; CEO Virginie Morgon to depart
Human microbiome
Seventure preps third generation of microbiome fund
Cem Baytok of Idacapital
Idacapital targets close to USD 30m for impact fund
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013